Assignee
ALECTOR LLC
US·48 granted patents·56 pending applications·97 citations·filing 2015–2025
Top patents by PatentIndex Score
104 records- 0196US11186645B2Isolated nucleic acids encoding anti-sortilin antibodiesALECTOR LLC·Filed 2020·Granted Nov 30, 2021·4 cites·48 claims
- 0296US10676525B2Anti-TREM2 antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Jun 9, 2020·13 cites·60 claims
- 0394US10087255B2Anti-sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2016·Granted Oct 2, 2018·12 cites·17 claims
- 0493US11208488B2Methods of increasing progranulin levels using anti-Sortilin antibodiesALECTOR LLC·Filed 2018·Granted Dec 28, 2021·4 cites·44 claims
- 0593US10849992B1Methods of screening for sortilin binding antagonistsALECTOR LLC·Filed 2016·Granted Dec 1, 2020·6 cites·8 claims
- 0693US10711062B2Anti-CD33 antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Jul 14, 2020·7 cites·77 claims
- 0791US11084875B2Anti-TREM2 antibodies and methods of use thereofALECTOR LLC·Filed 2019·Granted Aug 10, 2021·4 cites·26 claims
- 0891US10428150B2Anti-sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Oct 1, 2019·6 cites·17 claims
- 0991US2025092144A1Methods of use of anti-sortilin antibodies for treating a disease, disorder, or injuryALECTOR LLC·Filed 2024·Application pending·0 cites
- 1090US11965023B2Anti-Siglec-5 antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted Apr 23, 2024·1 cites·32 claims
- 1190US11634489B2Anti-TREM2 antibodies and methods of use thereofALECTOR LLC·Filed 2020·Granted Apr 25, 2023·2 cites·32 claims
- 1290US11254743B2Anti-CD33 antibodies and methods of use thereofALECTOR LLC·Filed 2020·Granted Feb 22, 2022·2 cites·20 claims
- 1390US10308718B2Anti-sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Jun 4, 2019·6 cites·21 claims
- 1489US11667699B2Anti-MS4A4A antibodies and methods of use thereofALECTOR LLC·Filed 2020·Granted Jun 6, 2023·3 cites·93 claims
- 1589US11339223B2Methods of use of anti-Sortilin antibodies for treating a disease, disorder, or injuryALECTOR LLC·Filed 2018·Granted May 24, 2022·2 cites·59 claims
- 1688US12258410B2Anti-SIRPα antibodies and methods of use thereofALECTOR LLC·Filed 2024·Granted Mar 25, 2025·0 cites·76 claims
- 1788US11396546B2Anti-Sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2019·Granted Jul 26, 2022·2 cites·22 claims
- 1886US11472874B2Anti-MS4A4A antibodies and methods of use thereofALECTOR LLC·Filed 2019·Granted Oct 18, 2022·3 cites·29 claims
- 1986US10800844B2Anti-Siglec-9 antibodies and methods of use thereofALECTOR LLC·Filed 2016·Granted Oct 13, 2020·2 cites·23 claims
- 2085US11174313B2Anti-CD33 antibodies and methods of use thereofALECTOR LLC·Filed 2016·Granted Nov 16, 2021·3 cites·16 claims
- 2184US12226482B2Anti-SIRP-alpha antibodies and methods of use thereofALECTOR LLC·Filed 2023·Granted Feb 18, 2025·0 cites·19 claims
- 2283US11779642B2Anti-SIRP-alpha antibodies and methods of use thereofALECTOR LLC·Filed 2017·Granted Oct 10, 2023·1 cites·20 claims
- 2383US11136390B2Anti-CD33 antibodies and methods of use thereofALECTOR LLC·Filed 2016·Granted Oct 5, 2021·3 cites·26 claims
- 2482US11319373B2Anti-SIRPA antibodies and methods of use thereofALECTOR LLC·Filed 2019·Granted May 3, 2022·1 cites·83 claims
- 2582US10875919B2Chimeric receptors and methods of use thereofALECTOR LLC·Filed 2017·Granted Dec 29, 2020·1 cites·8 claims
- 2682US2025297016A1Anti-sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2025·Application pending·0 cites
- 2781US11440957B2Anti-TMEM106B antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Sep 13, 2022·1 cites·43 claims
- 2881US11390680B2Anti-Siglec-7 antibodies and methods of use thereofALECTOR LLC·Filed 2020·Granted Jul 19, 2022·1 cites·30 claims
- 2981US2025092131A1Anti-TREM1 Antibodies and Methods of Use ThereofALECTOR LLC·Filed 2024·Application pending·0 cites
- 3080US2024067723A1Anti-siglec-9 antibodies and methods of use thereofALECTOR LLC·Filed 2023·Application pending·0 cites
- 3179US12247073B2Anti-CD33 antibodies and methods of use thereofALECTOR LLC·Filed 2019·Granted Mar 11, 2025·1 cites·84 claims
- 3279US12110327B2Anti-TREM1 antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted Oct 8, 2024·0 cites·22 claims
- 3379US11976119B2Anti-SIRPa antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted May 7, 2024·0 cites·91 claims
- 3479US2022185899A1Methods of increasing progranulin levels using anti-sortilin antibodiesALECTOR LLC·Filed 2021·Application pending·0 cites
- 3579US2022185898A1Methods of use of anti-sortilin antibodies for treating a disease, disorder, or injuryALECTOR LLC·Filed 2021·Application pending·0 cites
- 3678US11359014B2Anti-siglec-5 antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Jun 14, 2022·2 cites·25 claims
- 3778US10590198B2Anti-siglec-7 antibodies and methods of use thereofALECTOR LLC·Filed 2016·Granted Mar 17, 2020·2 cites·31 claims
- 3877US12358991B2Anti-Sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted Jul 15, 2025·0 cites·52 claims
- 3977US12297277B2Anti-sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted May 13, 2025·0 cites·53 claims
- 4077US11147249B2Siglec transgenic mice and methods of use thereofALECTOR LLC·Filed 2017·Granted Oct 19, 2021·1 cites·18 claims
- 4177US2025223365A1Methods of use of anti-sortilin antibodiesALECTOR LLC·Filed 2024·Application pending·0 cites
- 4276US2025026827A1Anti-SIRP-Beta1 Antibodies and Methods of Use ThereofALECTOR LLC·Filed 2024·Application pending·0 cites
- 4375US2023312712A1Anti-trem2 antibodies and methods of use thereofALECTOR LLC·Filed 2023·Application pending·0 cites
- 4475US2025179189A1Anti-SIRPa Antibodies and Methods of Use ThereofALECTOR LLC·Filed 2025·Application pending·0 cites
- 4575US2023107639A1Anti-trem2 antibodies and methods of use thereofALECTOR LLC·Filed 2022·Application pending·0 cites
- 4674US12331111B2Anti-MS4A4A antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted Jun 17, 2025·0 cites·24 claims
- 4774US12331112B2Anti-MS4A4A antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted Jun 17, 2025·0 cites·28 claims
- 4874US2024287204A1Anti-mertk antibodies and methods of use thereofALECTOR LLC·Filed 2023·Application pending·0 cites
- 4973US12258398B2Anti-Siglec-5 antibodies and methods of use thereofALECTOR LLC·Filed 2019·Granted Mar 25, 2025·1 cites·34 claims
- 5073US12004494B2Siglec transgenic mice and methods of use thereofALECTOR LLC·Filed 2021·Granted Jun 11, 2024·0 cites·22 claims
Showing the top 50 of 104 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ALECTOR LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →